Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. Sutures: The iconic Johnson & Johnson invention that revolutionized medicine
An infographic with fun facts about the history of Johnson & Johnson’s surgical sutures

Sutures: The iconic Johnson & Johnson invention that revolutionized medicine

To commemorate the month that the company first listed sutures in its 1887 inventory book, we’re unspooling fun facts about the ubiquitous medical innovation.

A common thread in Johnson & Johnson’s storied century-plus history is its commitment to innovation in healthcare. One of its most revolutionary inventions? The mass production of sterile surgical sutures, which forever changed the field of medicine, and helped improve the outcomes of patients going into the operating room for the better.

The revolutionary product first appeared in a Johnson & Johnson cash book (a business ledger listing inventory and expenditures) as “ligatures” in January 1887. Since then, suture innovation has continued at the company, leading to a long string of follow-up products that are changing the surgery game in their own right.

This infographic spins the full tale of the great history—and exciting future—of those signature sutures.

A graphic of surgical sutures

When you’ve been innovating for 140 years …

Discover more about the history of Johnson & Johnson.
Johnson & Johnson's new museum at its world headquarters in New Jersey
© Albert Vecerka/Esto. All rights reserved.

More from Johnson & Johnson

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

What is inflammation?

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.

What is IL-23?

This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.